Thursday, May 12th
Marriott Milwaukee West in Milwaukee, WI
7:30am Registration - 4:00pm Adjourn
To download a full copy of the agenda, click here.
PURPOSE OF THE SUMMITS
The Wisconsin HPV Vaccine Summits aim to improve HPV immunization rates throughout Wisconsin by providing:
- Current data on state-specific HPV disease epidemiology and immunization rates
- Updates on disease caused by HPV from regional experts
- Current information on HPV vaccine safety
- Discussions on how to address vaccine hesitancy
- Ways to advocate for organizational support of adolescent immunizations
- Best practices for improving timely completion of the entire HPV vaccine series
- A forum for sharing HPV-related quality improvement projects from across the state
- Discussion of the barriers faced in initiating and completing HPV immunizations
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Pediatrics (AAP) and the Wisconsin Chapter of the American Academy of Pediatrics (WIAAP). The American Academy of Pediatrics is accredited by the ACCME to provide continuing medical education for physicians.
The AAP designates this live activity for a maximum of 2.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is acceptable for a maximum of 2.50 AAP credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the American Academy of Pediatrics.
The American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME. Physician assistants may receive a maximum of 2.50 hours of Category 1 credit for completing this program.
This program is accredited for 2.50 NAPNAP CE contact hours of which 0 contain pharmacology (Rx), (0 related to psychopharmacology) (0 related to controlled substances), content per the National Association of Pediatric Nurse Practitioners (NAPNAP) Continuing Education Guidelines.
All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content.
* A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.